GlassScriptPhysician profile
Joanna Romano
NPI 1538831680
$3,582.42
in general payments reported to CMS, 2019-2025
21 companies · $1,100 in 2025
The $1,100 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.09 · 2022: $504 · 2023: $1,087 · 2024: $841 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,018 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,018.04 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $930.12 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $485.44 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Genzyme Corporation | $347.97 | 2022-2025 | |
| Ucb, INC. | $309.38 | 2021-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $224.52 | 2023-2024 | Sotyktu |
| Incyte Corporation | $214.49 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $178.14 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $167.41 | 2023-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $124.88 | 2024-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $118.47 | 2022-2025 | Dupixent |
| Pfizer INC. | $89.88 | 2025 | |
| Janssen Biotech, INC. | $75.08 | 2023-2025 | Tremfya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.66 | 2022-2024 | Spevigo |
| Dermavant Sciences, INC. | $51.57 | 2023 | Vtama |
| Novartis Pharmaceuticals Corporation | $50.14 | 2022-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $46.72 | 2022 | |
| Organon LLC | $28.60 | 2025 | Vtama |
| Botanix Sb INC | $21.77 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $18.74 | 2023 | Ycanth |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.97 | 2022 | |
| Arcutis Biotherapeutics, INC. | $16.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Romano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.